Vaughan David Investments Inc. IL Buys 1,558 Shares of Clorox Company (The) (NYSE:CLX)

Vaughan David Investments Inc. IL lifted its holdings in shares of Clorox Company (The) (NYSE:CLX) by 61.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,084 shares of the company’s stock after purchasing an additional 1,558 shares during the quarter. Vaughan David Investments Inc. IL’s holdings in Clorox were worth $297,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. American Beacon Advisors Inc. purchased a new stake in Clorox in the first quarter worth approximately $104,000. Parkside Financial Bank & Trust lifted its position in Clorox by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after purchasing an additional 29 shares during the last quarter. Valley National Advisers Inc. lifted its position in Clorox by 0.6% in the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock valued at $115,000 after purchasing an additional 5 shares during the last quarter. Blue Chip Partners Inc. lifted its position in Clorox by 3.9% in the second quarter. Blue Chip Partners Inc. now owns 941 shares of the company’s stock valued at $125,000 after purchasing an additional 35 shares during the last quarter. Finally, Sun Life Financial INC lifted its position in Clorox by 10,344.4% in the second quarter. Sun Life Financial INC now owns 940 shares of the company’s stock valued at $125,000 after purchasing an additional 931 shares during the last quarter. 73.39% of the stock is owned by institutional investors and hedge funds.

Shares of Clorox Company (CLX) traded up $0.35 during trading on Friday, hitting $139.64. The company had a trading volume of 912,445 shares, compared to its average volume of 725,419. The company has a debt-to-equity ratio of 3.02, a quick ratio of 0.77 and a current ratio of 1.10. The company has a market capitalization of $18,005.04, a P/E ratio of 25.16, a PEG ratio of 3.81 and a beta of 0.42. Clorox Company has a one year low of $113.01 and a one year high of $141.76.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. The company had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.48 billion. Clorox had a return on equity of 161.59% and a net margin of 11.84%. The firm’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.36 earnings per share. equities analysts predict that Clorox Company will post 5.58 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be issued a dividend of $0.84 per share. The ex-dividend date is Tuesday, January 23rd. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.41%. Clorox’s dividend payout ratio is presently 61.88%.

CLX has been the subject of several recent research reports. BMO Capital Markets reiterated a “buy” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, October 5th. Morgan Stanley lowered their price objective on Clorox from $138.00 to $128.00 and set an “equal weight” rating for the company in a research report on Thursday, November 2nd. Jefferies Group reiterated a “hold” rating and issued a $132.00 price objective on shares of Clorox in a research report on Wednesday, November 1st. Royal Bank Of Canada reiterated a “hold” rating and issued a $115.00 price objective on shares of Clorox in a research report on Sunday, October 8th. Finally, Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating in a research report on Monday, November 6th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and three have assigned a buy rating to the stock. Clorox currently has an average rating of “Hold” and an average price target of $128.72.

In other Clorox news, SVP Michael R. Costello sold 10,574 shares of the stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total value of $1,438,169.74. Following the completion of the transaction, the senior vice president now owns 34,867 shares in the company, valued at $4,742,260.67. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Matthew T. Laszlo sold 20,051 shares of the stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the transaction, the senior vice president now owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The disclosure for this sale can be found here. 1.00% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: This piece was posted by Week Herald and is owned by of Week Herald. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be read at https://weekherald.com/2017/12/04/clorox-company-the-clx-holdings-boosted-by-vaughan-david-investments-inc-il.html.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply